Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Yoji HIRAI"'
Autor:
Katsunori Manaka, Junichiro Sato, Yusuke Hikima, Hirofumi Horikoshi, Maho Taguchi, Akimichi Morita, Hiraku Suga, Hikari Boki, Taku Fujimura, Yoji Hirai, Takatoshi Shimauchi, Chiharu Tateishi, Eiji Kiyohara, Ikko Muto, Hideki Nakajima, Riichiro Abe, Kazuyasu Fujii, Chikako Nishigori, Eiji Nakano, Kentaro Yonekura, Takeru Funakoshi, Masahiro Amano, Tomomitsu Miyagaki, Reiko Yamashita, Makoto Sugaya, Toshihisa Hamada, Masaomi Nangaku, Taroh Iiri, Noriko Makita
Publikováno v:
Endocrine Journal, Vol 71, Iss 8, Pp 777-787 (2024)
Central hypothyroidism and dyslipidemia are well-known adverse events (AEs) of bexarotene therapy. Although hypothyroidism is known to cause dyslipidemia, no study has examined the association between hypothyroidism and dyslipidemia in patients under
Externí odkaz:
https://doaj.org/article/db10afb4e2ca4574be48c145484d1872
Autor:
Daisuke Kawakami, Yoshiko Oda, Yumi Oka, Anri Morita, Keiko Kuroda, Yoji Hirai, Chikako Nishigori, Atsushi Fukunaga
Publikováno v:
Journal of Cutaneous Immunology and Allergy, Vol 6, Iss 5, Pp 172-174 (2023)
Abstract An 81‐year‐old Japanese man presented with a history of recurrent eyelid swelling and purpura on the face, neck, and limbs. Because the initial clinical presentation was angioedema alone, the patient was treated with an H1‐receptor ant
Externí odkaz:
https://doaj.org/article/f9ceb14978f44a36b9245efb9306d238
Autor:
Mari Matsumoto, Yoshio Kawakami, Tomoko Miyake, Yoji Hirai, Hitomi Kataoka, Fumio Otsuka, Shin Morizane
Publikováno v:
Journal of Cutaneous Immunology and Allergy, Vol 6, Iss 5, Pp 194-195 (2023)
A 43‐year‐old woman developed angioedema‐like eyelid edema on day +6 after the second NVX‐CoV2373 vaccination. Short‐term oral prednisolone treatment resulted in complete resolution of the eyelid edema.
Externí odkaz:
https://doaj.org/article/f3df91fc8b884507a1596cbc7cad153f
Autor:
Yuki Akamatsu, Yoshio Kawakami, Shusaku Fujita, Tomoko Kawamoto, Tomoko Miyake, Yoji Hirai, Shin Morizane
Publikováno v:
Journal of Cutaneous Immunology and Allergy, Vol 6, Iss 5, Pp 196-197 (2023)
A 27‐year‐old woman developed dyspnea and wheezing within 10 min after eating a piece of raspberry walnut cake, and was successfully treated with intravenous corticosteroid and intramuscular injection of adrenaline. An open oral provocation test
Externí odkaz:
https://doaj.org/article/c1917b03af8f479ab24f60e862a53fe3
Autor:
Mayu Tokuda, Yoshio Kawakami, Yoji Hirai, Kota Tachibana, Yuki Nakagawa, Satoru Sugihara, Tomoko Miyake, Osamu Yamasaki, Keiko Manabe, Shin Morizane
Publikováno v:
Indian Journal of Dermatology, Vol 68, Iss 4, Pp 468-470 (2023)
Externí odkaz:
https://doaj.org/article/bd242dabcb5e45879c599a7b1724b984
Publikováno v:
Journal of Cutaneous Immunology and Allergy, Vol 6, Iss 3, Pp 115-116 (2023)
A 37‐year‐old woman developed persistent low‐grade fever (37.2°C) on day +13 after the first dose of BNT162b2 mRNA vaccine. She noticed coin‐sized hair loss on day +22, and it became widespread within 1 week. The patient's hair mostly recove
Externí odkaz:
https://doaj.org/article/c4b011d866f04b5aaef01bf3fa32732d
Autor:
Masayuki Takahashi, Yoji Hirai, Akemi Senoo, Takenobu Yamamoto, Masato Yashiro, Shin Morizane
Publikováno v:
Journal of Cutaneous Immunology and Allergy, Vol 3, Iss 2, Pp 39-40 (2020)
Externí odkaz:
https://doaj.org/article/d233c0ecabf04ad89d0574ccad81856b
Autor:
Hayato Nomura, Mutsumi Suganuma, Takuya Takeichi, Michihiro Kono, Yuki Isokane, Ko Sunagawa, Mina Kobashi, Satoru Sugihara, Ai Kajita, Tomoko Miyake, Yoji Hirai, Osamu Yamasaki, Masashi Akiyama, Shin Morizane
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 3, p 913 (2020)
The serine proteases kallikrein-related peptidase (KLK) 5 and KLK7 cleave cell adhesion molecules in the epidermis. Aberrant epidermal serine protease activity is thought to play an important role in the pathogenesis of atopic dermatitis (AD). We col
Externí odkaz:
https://doaj.org/article/0441729443914c58b372341f2b86a362
Autor:
Masayuki Takahashi, Emi Yokoyama, Chinatsu Yasuhara, Tomoko Hashimoto, Tomoko Miyake, Yoji Hirai, Tatsuya kaji, Yoshio Kawakami, Osamu Yamasaki, Shin Morizane
Publikováno v:
Journal of Cutaneous Immunology and Allergy, Vol 2, Iss 4, Pp 115-116 (2019)
Externí odkaz:
https://doaj.org/article/e8186a0178a14912bcaac3bf67f5e155
Autor:
Jun Yamagami, Yuichi Kurihara, Takeru Funakoshi, Yasuko Saito, Ryo Tanaka, Hayato Takahashi, Hideyuki Ujiie, Hiroaki Iwata, Yoji Hirai, Keiji Iwatsuki, Norito Ishii, Jun Sakurai, Takayuki Abe, Ryo Takemura, Naomi Mashino, Masahiro Abe, Masayuki Amagai
Publikováno v:
The Journal of Dermatology. 50:175-182
This was a multicenter clinical trial of rituximab, a chimeric monoclonal IgG antibody directed against CD20, for the treatment of refractory pemphigus vulgaris and pemphigus foliaceus. In total, 20 patients were treated with two doses of rituximab (